Home / Companies / News / Sun Pharma Q4 profit declines 37% to Rs 399 cr on one-time exceptional loss

Sun Pharma Q4 profit declines 37% to Rs 399 cr on one-time exceptional loss

The company had posted a net profit of Rs 635.88 crore in the same period previous fiscal, Sun Pharma said in a BSE filing

Premium

For the fiscal ended March 2020, the net profit of the company was at Rs 3,764.93 crore as against Rs 2,665.42 crore in the previous fiscal, Sun Pharma said

BS Web Team PTI New Delhi

2 min read Last Updated : May 27 2020 | 6:39 PM IST

Pharma major Sun Pharmaceutical Industries on Wednesday reported a 37.12 per cent decline in its consolidated net profit to Rs 399.84 crore for the quarter ended March 2020, mainly on account of one-time exceptional loss.

The company had posted a net profit of Rs 635.88 crore in the same period previous fiscal, Sun Pharma said in a BSE filing.

Consolidated revenue from operations stood at Rs 8,184.94 crore for the quarter under consideration as against Rs 7,163.92 crore in the same period a year ago,it added.

The company had a one-time exceptional loss of Rs 260.64 crore in the quarter ended March 2020,

Topics : Sun Pharma Q4 Results BSE dividend

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in